IPRIPR2018-01670Final Written Decision
Mylan Pharmaceuticals Inc. et al.v.Sanofi-Aventis Deutshland GmbH et al.
IPR challenge of US 8679069.
Type
IPR
Filed
Sep 10, 2018
Instituted
Apr 3, 2019
Decided
—
Patent
Application
12944544
Inventor
Robert Frederick Veasey et al
Granted
Mar 25, 2014
01
Timeline
3 milestones
2018-09-10Petition filed
2019-04-03Institution
2020-04-02Terminated
02
Parties & counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Counsel
Torczon, Richardet al
Patent Owner
Sanofi-Aventis Deutshland GmbH et al.
Counsel
Weiswasser, Elizabeth Stotlandet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →